20/20 Biolabs, Inc Common Stock
Quarterly Financials
| Values in thousands | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 |
|---|---|---|---|---|
Revenue | $730 | $353 | $538 | $417 |
Gross Profit | 304 | 62 | 130 | 145 |
EBITDA | -1,227 | -1,893 | -894 | -780 |
EBIT | -1,244 | -1,907 | -912 | -800 |
Net Income | -1,506 | -2,174 | -1,307 | -825 |
Net Change In Cash | 730 | 353 | 538 | 417 |
Free Cash Flow | -600 | -1,288 | -511 | -385 |
Cash | 4,546 | 4,219 | 1,025,987 | 1,144 |
Basic Shares | 10,790 | 10,616 | 10,442 | 4,856 |
Annual Financials
| Values in thousands | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
Revenue | $2,045 | $1,752 | $1,424 | $11,059 |
Gross Profit | 604 | 360 | 109 | 5,121 |
EBITDA | -3,504 | -5,525 | -6,194 | 1,967 |
EBIT | -3,582 | -5,661 | -6,361 | 1,678 |
Net Income | -3,738 | -5,551 | -6,391 | 2,186 |
Net Change In Cash | 2,045 | 1,752 | 1,424 | 11,059 |
Free Cash Flow | -1,919,720 | -2,598 | -4,637 | 5,541 |
Cash | 1,025,987 | 1,784 | 4,089 | 8,807 |
Basic Shares | 6,256 | 4,800 | 4,768 | 9,487 |
Earnings Calls
| Quarter | EPS |
|---|---|
2026-06-30 | -$0.26 |
2026-03-31 | -$0.28 |
2025-12-31 | -$0.12 |